History and development of biliary surgery
-
摘要: 胆道外科是普通外科的主要分支,在外科学领域中占有极为重要的地位。胆道疾病的病理和临床表现极为复杂,因而胆道外科手术在现今的消化系统外科手术中仍然最具挑战性。当前,随着微创技术和内镜技术的发展,胆道外科正经历着一场深刻的理论与技术革新,这些研究将构成21世纪胆道外科可持续发展的重要基石,应该引起更广泛的重视。Abstract: Biliary surgery is the main branch of general surgery,which plays an important role in the field of surgery. The pathological and clinical manifestations of biliary diseases are very complex,so biliary surgery is still the most challenging surgery in the digestive system.With the development of minimally invasive technology and endoscopic technology,biliary surgery is undergoing a profound theoretical and technological innovation,and these studies will form an important foundation for the sustainable development of biliary surgery in the 21 st century and should be paid more attention.
-
Key words:
- biliary surgery /
- history /
- laparoscopic /
- robotic surgery
-
[1] CHUANG SH,LIN CS. Single-incision laparoscopic surgery for biliary tract disease[J]. World J Gastroenterol,2016,22(2):736-747. [2] VAKAYIL V,KLINKER ST,SULCINER ML,et al. Singlestage management of choledocholithiasis:Intraoperative ERCP versus laparoscopic common bile duct exploration[J].Surg Endosc,2019.[Epub ahead of print] [3] di MAURO D,RICCIARDI E,SIRAGUSA L,et al. Outcome of laparoscopic common bile duct exploration after failed endoscopic retrograde cholangiopancreatography:A comparative study[J]. J Laparoendosc Adv Surg Tech A,2019,29(11):1391-1396. [4] BALLOU J,WANG Y,SCHREIBER M,et al. 10 years of laparoscopic common bile duct exploration:A single tertiary institution experience[J]. Am J Surg,2019,217(5):970-973. [5] YAO C,TIAN Y,YAO D,et al. T-tube-free single-incision laparoscopic common bile duct exploration plus cholecystectomy:A single centre experience[J]. ANZ J Surg,2019,89(7-8):895-899. [6] LIU X,LUO,CHEN H,et al. Application of barbed sutures in laparoscopic common bile duct exploration:A retrospective analysis[J]. Surg Laparosc Endosc Percutan Tech,2018,28(5):324-327. [7] HAJIBANDEH S,HAJIBANDEH S,SARMA DR,et al. Laparoscopic transcystic versus transductal common bile duct exploration:A systematic review and meta-analysis[J]. World J Surg,2019,43(8):1935-1948. [8] VALDERRAMA-TREVIO AI,GRANADOS-ROMERO JJ,ESPEJEL-DELOIZA M,et al. Updates in Mirizzi syndrome[J]. Hepatobiliary Surg Nutr,2017,6(3):170-178. [9] CHEN H,SIWO EA,KHU M,et al. Current trends in the management of Mirizzi syndrome:A review of literature[J]. Medicine(Baltimore),2018,97(4):e9691. [10] CLEMENTE G,TRINGALI A,de ROSE AM,et al. Mirizzi syndrome:Diagnosis and management of a challenging biliary disease[J]. Can J Gastroenterol Hepatol, 2018, 2018:6962090. [11] NAG HH,NEKARAKANTI PK. Laparoscopic versus open surgical management of patients with Mirizzi’s syndrome:A comparative study[J]. J Minim Access Surg,2019.[Epub ahead of print] [12] MAHER H,JIN W,MOU Y,et al. The prospective of laparoscopic pancreaticoduodenectomy for cancer management[J]. Chin Clin Oncol,2017,6(1):8. [13] UMEMURA A,NITTA H,TAKAHARA T,et al. Current status of laparoscopic pancreaticoduodenectomy and pancreatectomy[J]. Asian J Surg,2018,41(2):106-114. [14] KIM H,SONG KB,HWANG DW,et al. Laparoscopic versus open pancreaticoduodenectomy for pancreatic neuroendocrine tumors:A single-center experience[J]. Surg Endosc,2019,33(12):4177-4185. [15] TORPHY RJ,FRIEDMAN C,HALPERN A,et al. Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers[J]. Ann Surg,2019,270(6):1147-1155. [16] MUNRO MG. The surgical“robot”in benign gynecology:Surgical advance or a set of costly training wheels[J]. J Minim Invasive Gynecol,2016,23(1):1-4. [17] ZHOU NX,CHEN JZ,LIU QD,et al. One hundred eighty cases of general surgeries under da vinci surgical system in single institute in China[J]. Chin J Bases Clin Gen Surg,2011,18(7):698-704.(in Chinese)周宁新,陈军周,刘全达,等.“达芬奇”机器人普通外科手术180例:中国单中心报道[J].中国普外基础与临床杂志,2011,18(7):698-704. [18] DOU KF,ZHOU JS. Some problems in biliary surgery[J].Chin J Exp Surg,2007,24(12):1452-1453.(in Chinese)窦科峰,周景师.胆道外科中应该重视的几个问题[J].中华实验外科杂志,2007,24(12):1452-1453. [19] COPUR MS,MERANI S,VARGAS LM. Biliary cancer:Current multimodality treatment and future directions[J]. Oncology(Williston Park),2019,33(9):685003. [20] SIMILE MM,BAGELLA P,VIDILI G,et al. Targeted therapies in cholangiocarcinoma:Emerging evidence from clinical trials[J]. Medicina(Kaunas),2019,55(2):e42. [21] SIMBOLO M,FASSAN M,RUZZENENTE A,et al. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups[J]. Oncotarget,2014,5(9):2839-2852. [22] BRIDGEWATER JA,GOODMAN KA,KALYAN A,et al. Biliary tract cancer:Epidemiology,radiotherapy,and molecular profiling[J]. Am Soc Clin Oncol Educ Book,2016,35:e194-e203. [23] MERTENS JC,RIZVI S,GORES GJ. Targeting cholangiocarcinoma[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(4 Pt B):1454-1460.
本文二维码
计量
- 文章访问数: 1245
- HTML全文浏览量: 51
- PDF下载量: 320
- 被引次数: 0